InSphero nabs Series C funds
InSphero AG has raised CHF 20 million in Series C funding. The investor was an unnamed family investment office. Headquartered in Schlieren, Switzerland, InSphero is a solutions provider for 3D cell culture models and body-on-a-chip systems.
8 July 2015•3 mins read
